Skip to main content
Top
Published in: Diabetologia 9/2011

01-09-2011 | Article

Incidence and progression of diabetic retinopathy in Japanese adults with type 2 diabetes: 8 year follow-up study of the Japan Diabetes Complications Study (JDCS)

Authors: R Kawasaki, S Tanaka, S Tanaka, T Yamamoto, H Sone, Y Ohashi, Y Akanuma, N Yamada, H Yamashita, on behalf of the Japan Diabetes Complications Study Group

Published in: Diabetologia | Issue 9/2011

Login to get access

Abstract

Aims/hypothesis

The aim of this study was to determine the incidence and progression rates of diabetic retinopathy and their associations in Japanese individuals with type 2 diabetes.

Methods

This is a part of the Japan Diabetic Complications Study (JDCS), a multi-centred randomised trial of type 2 diabetes patients aged 40–70 years with an 8 year follow-up. There were 1,221 patients without diabetic retinopathy at baseline; incidence of diabetic retinopathy was defined as the development of any diabetic retinopathy. There were 410 patients with mild non-proliferative diabetic retinopathy at baseline; progression of diabetic retinopathy was defined as the development of severe non-proliferative diabetic retinopathy or proliferative diabetic retinopathy. We used multivariate proportional Cox hazard models, and generalised additive models were also applied to identify potential threshold effect.

Results

The incidence and progression rate of diabetic retinopathy was 38.3/1,000 person-years and 21.1/1,000 person-years, respectively. Higher HbA1c (adjusted HR [aHR] per 1% [10.9 mmol/mol] 1.36 [95% CI 1.28–1.45]), longer duration of diabetes (aHR per 5 year period 1.26 [95% CI 1.17–1.35]), higher systolic blood pressure (aHR per +10 mmHg 1.01 [95% CI 1.00–1.02]) and higher body mass index (aHR per 1 kg/m2 1.05 [95% CI 1.00–1.09]) were associated with incident diabetic retinopathy. The association between HbA1c and incident diabetic retinopathy was linear; the association with duration of diabetes increased rapidly between 5 and 10 years. Higher HbA1c was also associated with progression of diabetic retinopathy (aHR per 1% [10.9 mmol/mol] 1.66 [95% CI 1.41–1.96]).

Conclusions

Observed incidence and progression rates of diabetic retinopathy seemed lower than that in western populations. HbA1c was the only factor associated with both incidence and progression of diabetic retinopathy. The strength of the association between duration of diabetes and incidence of diabetic retinopathy increased rapidly during a period of 5 to 10 years duration of diabetes.

Trial registration:

Funding:

This study is supported by the Ministry of Health, Labour and Welfare, Japan.
Literature
1.
go back to reference Mohamed Q, Gillies MC, Wong TY (2007) Management of diabetic retinopathy: a systematic review. JAMA 298:902–916PubMedCrossRef Mohamed Q, Gillies MC, Wong TY (2007) Management of diabetic retinopathy: a systematic review. JAMA 298:902–916PubMedCrossRef
2.
go back to reference Vallance JH, Wilson PJ, Leese GP, McAlpine R, MacEwen CJ, Ellis JD (2008) Diabetic retinopathy: more patients, less laser: a longitudinal population-based study in Tayside, Scotland. Diabetes Care 31:1126–1131PubMedCrossRef Vallance JH, Wilson PJ, Leese GP, McAlpine R, MacEwen CJ, Ellis JD (2008) Diabetic retinopathy: more patients, less laser: a longitudinal population-based study in Tayside, Scotland. Diabetes Care 31:1126–1131PubMedCrossRef
3.
go back to reference Misra A, Bachmann MO, Greenwood RH et al (2009) Trends in yield and effects of screening intervals during 17 years of a large UK community-based diabetic retinopathy screening programme. Diabet Med 26:1040–1047PubMedCrossRef Misra A, Bachmann MO, Greenwood RH et al (2009) Trends in yield and effects of screening intervals during 17 years of a large UK community-based diabetic retinopathy screening programme. Diabet Med 26:1040–1047PubMedCrossRef
4.
go back to reference Wong TY, Mwamburi M, Klein R et al (2009) Rates of progression in diabetic retinopathy during different time periods: a systematic review and meta-analysis. Diabetes Care 32:2307–2313PubMedCrossRef Wong TY, Mwamburi M, Klein R et al (2009) Rates of progression in diabetic retinopathy during different time periods: a systematic review and meta-analysis. Diabetes Care 32:2307–2313PubMedCrossRef
5.
go back to reference Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047–1053PubMedCrossRef Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047–1053PubMedCrossRef
6.
go back to reference Zimmet P, Alberti KG, Shaw J (2001) Global and societal implications of the diabetes epidemic. Nature 414:782–787PubMedCrossRef Zimmet P, Alberti KG, Shaw J (2001) Global and societal implications of the diabetes epidemic. Nature 414:782–787PubMedCrossRef
7.
go back to reference International Diabetes Federation (2009) IDF Diabetes Atlas 2009. In: Federation ID (ed) International Diabetes Federation, Brussels, Belgium International Diabetes Federation (2009) IDF Diabetes Atlas 2009. In: Federation ID (ed) International Diabetes Federation, Brussels, Belgium
8.
go back to reference Klein R, Knudtson MD, Lee KE, Gangnon R, Klein BE (2008) The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology 115:1859–1868PubMedCrossRef Klein R, Knudtson MD, Lee KE, Gangnon R, Klein BE (2008) The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology 115:1859–1868PubMedCrossRef
9.
go back to reference Grauslund J, Green A, Sjolie AK (2009) Prevalence and 25 year incidence of proliferative retinopathy among Danish type 1 diabetic patients. Diabetologia 52:1829–1835PubMedCrossRef Grauslund J, Green A, Sjolie AK (2009) Prevalence and 25 year incidence of proliferative retinopathy among Danish type 1 diabetic patients. Diabetologia 52:1829–1835PubMedCrossRef
10.
go back to reference Varma R, Choudhury F, Klein R et al (2010) Four-year incidence and progression of diabetic retinopathy and macular edema: the Los Angeles Latino Eye Study. Am J Ophthalmol 149:752–761PubMedCrossRef Varma R, Choudhury F, Klein R et al (2010) Four-year incidence and progression of diabetic retinopathy and macular edema: the Los Angeles Latino Eye Study. Am J Ophthalmol 149:752–761PubMedCrossRef
11.
go back to reference Chen MS, Kao CS, Fu CC, Chen CJ, Tai TY (1995) Incidence and progression of diabetic retinopathy among non-insulin-dependent diabetic subjects: a 4-year follow-up. Int J Epidemiol 24:787–795PubMedCrossRef Chen MS, Kao CS, Fu CC, Chen CJ, Tai TY (1995) Incidence and progression of diabetic retinopathy among non-insulin-dependent diabetic subjects: a 4-year follow-up. Int J Epidemiol 24:787–795PubMedCrossRef
12.
go back to reference Janghorbani M, Amini M, Ghanbari H, Safaiee H (2003) Incidence of and risk factors for diabetic retinopathy in Isfahan, Iran. Ophthalmic Epidemiol 10:81–95PubMedCrossRef Janghorbani M, Amini M, Ghanbari H, Safaiee H (2003) Incidence of and risk factors for diabetic retinopathy in Isfahan, Iran. Ophthalmic Epidemiol 10:81–95PubMedCrossRef
13.
go back to reference Kim HK, Kim CH, Kim SW et al (1998) Development and progression of diabetic retinopathy in Koreans with NIDDM. Diabetes Care 21:134–138PubMedCrossRef Kim HK, Kim CH, Kim SW et al (1998) Development and progression of diabetic retinopathy in Koreans with NIDDM. Diabetes Care 21:134–138PubMedCrossRef
14.
go back to reference Sasaki A, Horiuchi N, Hasewgawa K, Uehara M (1990) Development of diabetic retinopathy and its associated risk factors in type 2 diabetic patients in Osaka district, Japan: a long-term prospective study. Diabetes Res Clin Pract 10:257–263PubMedCrossRef Sasaki A, Horiuchi N, Hasewgawa K, Uehara M (1990) Development of diabetic retinopathy and its associated risk factors in type 2 diabetic patients in Osaka district, Japan: a long-term prospective study. Diabetes Res Clin Pract 10:257–263PubMedCrossRef
15.
go back to reference Klein R, Klein BE, Moss SE, Davis MD, DeMets DL (1984) The Wisconsin Epidemiologic Study of Diabetic Retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 102:527–532PubMed Klein R, Klein BE, Moss SE, Davis MD, DeMets DL (1984) The Wisconsin Epidemiologic Study of Diabetic Retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 102:527–532PubMed
16.
go back to reference Okudaira M, Yokoyama H, Otani T, Uchigata Y, Iwamoto Y (2000) Slightly elevated blood pressure as well as poor metabolic control are risk factors for the progression of retinopathy in early-onset Japanese type 2 diabetes. J Diabetes Complications 14:281–287PubMedCrossRef Okudaira M, Yokoyama H, Otani T, Uchigata Y, Iwamoto Y (2000) Slightly elevated blood pressure as well as poor metabolic control are risk factors for the progression of retinopathy in early-onset Japanese type 2 diabetes. J Diabetes Complications 14:281–287PubMedCrossRef
17.
go back to reference Shiraiwa T, Kaneto H, Miyatsuka T et al (2005) Post-prandial hyperglycemia is an important predictor of the incidence of diabetic microangiopathy in Japanese type 2 diabetic patients. Biochem Biophys Res Commun 336:339–345PubMedCrossRef Shiraiwa T, Kaneto H, Miyatsuka T et al (2005) Post-prandial hyperglycemia is an important predictor of the incidence of diabetic microangiopathy in Japanese type 2 diabetic patients. Biochem Biophys Res Commun 336:339–345PubMedCrossRef
18.
go back to reference Shiraiwa T, Kaneto H, Miyatsuka T et al (2005) Postprandial hyperglycemia is a better predictor of the progression of diabetic retinopathy than HbA1c in Japanese type 2 diabetic patients. Diabetes Care 28:2806–2807PubMedCrossRef Shiraiwa T, Kaneto H, Miyatsuka T et al (2005) Postprandial hyperglycemia is a better predictor of the progression of diabetic retinopathy than HbA1c in Japanese type 2 diabetic patients. Diabetes Care 28:2806–2807PubMedCrossRef
19.
go back to reference American Diabetes Association (2010) Standards of medical care in diabetes. Diabetes Care 33(Suppl 1):S11–S61CrossRef American Diabetes Association (2010) Standards of medical care in diabetes. Diabetes Care 33(Suppl 1):S11–S61CrossRef
20.
go back to reference Sone H, Katagiri A, Ishibashi S et al (2002) Effects of lifestyle modifications on patients with type 2 diabetes: the Japan Diabetes Complications Study (JDCS) study design, baseline analysis and three year-interim report. Horm Metab Res 34:509–515PubMedCrossRef Sone H, Katagiri A, Ishibashi S et al (2002) Effects of lifestyle modifications on patients with type 2 diabetes: the Japan Diabetes Complications Study (JDCS) study design, baseline analysis and three year-interim report. Horm Metab Res 34:509–515PubMedCrossRef
21.
go back to reference Sone H, Tanaka S, Iimuro S et al (2010) Long-term lifestyle intervention lowers the incidence of stroke in Japanese patients with type 2 diabetes: a nationwide multicentre randomised controlled trial (the Japan Diabetes Complications Study). Diabetologia 53:419–428PubMedCrossRef Sone H, Tanaka S, Iimuro S et al (2010) Long-term lifestyle intervention lowers the incidence of stroke in Japanese patients with type 2 diabetes: a nationwide multicentre randomised controlled trial (the Japan Diabetes Complications Study). Diabetologia 53:419–428PubMedCrossRef
22.
go back to reference Wilkinson CP, Ferris FL 3rd, Klein RE et al (2003) Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 110:1677–1682PubMedCrossRef Wilkinson CP, Ferris FL 3rd, Klein RE et al (2003) Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 110:1677–1682PubMedCrossRef
23.
go back to reference Klein R, Klein BE, Moss SE, Cruickshanks KJ (1998) The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology 105:1801–1815PubMedCrossRef Klein R, Klein BE, Moss SE, Cruickshanks KJ (1998) The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology 105:1801–1815PubMedCrossRef
24.
go back to reference Cikamatana L, Mitchell P, Rochtchina E, Foran S, Wang JJ (2007) Five-year incidence and progression of diabetic retinopathy in a defined older population: the Blue Mountains Eye Study. Eye (Lond) 21:465–471 Cikamatana L, Mitchell P, Rochtchina E, Foran S, Wang JJ (2007) Five-year incidence and progression of diabetic retinopathy in a defined older population: the Blue Mountains Eye Study. Eye (Lond) 21:465–471
25.
go back to reference Sone H, Ito H, Ohashi Y, Akanuma Y, Yamada N (2003) Obesity and type 2 diabetes in Japanese patients. Lancet 361:85PubMedCrossRef Sone H, Ito H, Ohashi Y, Akanuma Y, Yamada N (2003) Obesity and type 2 diabetes in Japanese patients. Lancet 361:85PubMedCrossRef
Metadata
Title
Incidence and progression of diabetic retinopathy in Japanese adults with type 2 diabetes: 8 year follow-up study of the Japan Diabetes Complications Study (JDCS)
Authors
R Kawasaki
S Tanaka
S Tanaka
T Yamamoto
H Sone
Y Ohashi
Y Akanuma
N Yamada
H Yamashita
on behalf of the Japan Diabetes Complications Study Group
Publication date
01-09-2011
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 9/2011
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-011-2199-0

Other articles of this Issue 9/2011

Diabetologia 9/2011 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.